Evidence map›Paper›PMID 26802146›Full record

ArticleBioscience reports2016

Novel compound heterozygous mutation in the CNGA1 gene underlie autosomal recessive retinitis pigmentosa in a Chinese family.

Xin Jin, Ling-Hui Qu, Bao-Ke Hou, Hai-Wei Xu, Xiao-Hong Meng, Chi-Pui Pang, Zheng-Qin Yin

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 20 citations in OpenAlex.

  1. Clinical and Molecular Features ofOphthalmology science · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. cGMP Signaling in Photoreceptor Degeneration.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Article
  8. Genetic dissection of non-syndromic retinitis pigmentosa.Indian journal of ophthalmology · 2022
    Review
  9. Novel mutations in theInternational journal of ophthalmology · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Sensing through Non-Sensing Ocular Ion Channels.International journal of molecular sciences · 2020
    Review
  14. Article
  15. Article
  16. Novel mutations inMolecular vision · 2019
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Xin JinSouthwest Hospital, Southwest Eye Hospital, Third Military Medical University, Chongqing 400038, China Department of Ophthalmology, General Hospital of Chinese PLA, Beijing 100853, China Key Lab of Visual Damage and Regeneration & Restoration of Chongqing, Chongqing 400038, China.
Ling-Hui QuSouthwest Hospital, Southwest Eye Hospital, Third Military Medical University, Chongqing 400038, China Key Lab of Visual Damage and Regeneration & Restoration of Chongqing, Chongqing 400038, China.
Bao-Ke HouSouthwest Hospital, Southwest Eye Hospital, Third Military Medical University, Chongqing 400038, China Department of Ophthalmology, General Hospital of Chinese PLA, Beijing 100853, China Key Lab of Visual Damage and Regeneration & Restoration of Chongqing, Chongqing 400038, China.
Hai-Wei XuSouthwest Hospital, Southwest Eye Hospital, Third Military Medical University, Chongqing 400038, China Key Lab of Visual Damage and Regeneration & Restoration of Chongqing, Chongqing 400038, China.
Xiao-Hong MengSouthwest Hospital, Southwest Eye Hospital, Third Military Medical University, Chongqing 400038, China Key Lab of Visual Damage and Regeneration & Restoration of Chongqing, Chongqing 400038, China.
Chi-Pui PangDepartment of Ophthalmology and Visual Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR 999077, China zhengqinyin253@126.com chipuipang@163.com.
Zheng-Qin YinSouthwest Hospital, Southwest Eye Hospital, Third Military Medical University, Chongqing 400038, China Department of Ophthalmology, General Hospital of Chinese PLA, Beijing 100853, China Key Lab of Visual Damage and Regeneration & Restoration of Chongqing, Chongqing 400038, China zhengqinyin253@126.com chipuipang@163.com.
Army Medical University · CNChinese PLA General Hospital · CNSouthwest Hospital · CNChinese University of Hong Kong · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinitis pigmentosa (RP) describes a group of inherited retinopathies that are characterized by the progressive degeneration of photoreceptor neurons, which causes night blindness, a reduction in the peripheral visual field and decreased visual acuity. More than 50 RP-related genes have been identified. In the present study, we analysed a Chinese family with autosomal recessive RP. We identified a compound heterozygous mutation, c.265delC and c.1537G>A, in CNGA1 using targeted next-generation sequencing (NGS) of RP-causing genes. The mutations were validated in the family members by Sanger sequencing. The mutations co-segregated with the RP phenotype and were absent from ethnically-matched control chromosomes. The mutant (mut) CNGA1 p.(G513R) protein caused by the mis-sense novel mutation c.1537G>A was expressed in vitro. The mut CNGA1 p.(G513R) protein was largely retained inside the cell rather than being targeted to the plasma membrane, suggesting the absence of cGMP-gated cation channels in the plasma membrane would be deleterious to rod photoreceptors, leading lead to RP.

Indexed as

FamilyHeterozygoteMutation, MissenseAmino Acid SubstitutionAsian PeopleCyclic Nucleotide-Gated Cation ChannelsFemaleHumansMaleRetinitis PigmentosaCNGA1 protein, humanCyclic Nucleotide-Gated Cation ChannelsCNGA1mutationnext-generation sequencingretinitis pigmentosa

Identifiers

PMID26802146
PMCPMC4725244
OpenAlexW2333945221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.